A recent analysis reveals that the number of chronic kidney disease (CKD) cases in women around the globe nearly tripled in the past three decades. Also, type 2 diabetes and hypertension were the leading causes of CKD-related deaths in women. The research will be presented at ASN Kidney Week 2024 October 23– 27.
The analysis drew from the Global Burden of Disease study 2021, a comprehensive effort to quantify health loss across the world over time. The study includes information from 204 countries and territories.
From 1990 to 2021, the average annual percentage change in CKD prevalence in women increased by 2.10%, mortality by 3.39%, and disability-adjusted life years by 2.48%. There have also been significant disparities in CKD-related mortality and morbidity across the world, with marked increases observed particularly in Latin America, North America, and among older adults. The study showed an alarming increased mortality rate attributable to metabolic risk factor over the last decade after a slight decrease between 2000 and 2010.
This calls for immediate policy interventions, targeted prevention programs, and investment in health care infrastructure to curb the rise of CKD, particularly in high-risk regions. Public awareness campaigns about the importance of early diagnosis, healthy lifestyles, and the management of underlying conditions like diabetes and hypertension are critical. Without swift action, the continued rise of CKD could overwhelm health care systems and lead to increased mortality and morbidity worldwide."
Hardik Dineshbhai Desai, MBBS, Senior Author, Independent Clinical and Public Health Researcher of the Gujarat Adani Institute of Medical Science, India
Study: "Global, National, and Regional Trends in the Burden of Chronic Kidney Disease among Women from 1990- 2021: A Comprehensive Global Analysis"
GLP-1 receptor agonists reduce kidney failure risk and cardiovascular events